References
- Blancato J, Singh B, Liu A, et al (2004). Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer, 90, 1612-9. https://doi.org/10.1038/sj.bjc.6601703
- Bonnett B, Egenvall NA, Hedhammar A, et al (2005). Mortality in over 350000 insured Swedish dogs from 1995-2000: I. Breed, gender, age and cause specific rates. Acta Vet Scand, 46, 105-20. https://doi.org/10.1186/1751-0147-46-105
- Chen CH, Shen J, Lee WJ, et al (2005). Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer. Int J Gynecol Cancer, 15, 878-83. https://doi.org/10.1111/j.1525-1438.2005.00150.x
- De Jonage-Canonico MB, Lenoir V, Martin A, et al (2003). Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. Breast Cancer Res Treat, 79, 365-77. https://doi.org/10.1023/A:1024059824430
- Deming SL, Nass SJ, Dickson RB, et al (2000). c-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer, 83, 1688-95. https://doi.org/10.1054/bjoc.2000.1522
- Evan G (2012). Taking a back door to target Myc. Science, 335, 293-4. https://doi.org/10.1126/science.1217819
- Fisher B, Costantino JP, Wickerham DL, et al (1998). Tamoxifen for the prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst, 90, 1371-88. https://doi.org/10.1093/jnci/90.18.1371
- Guenin S, Mauriat M, Pelloux J, et al (2009). Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot, 60, 487-93. https://doi.org/10.1093/jxb/ern305
- Gullino PM, Pettingrew HM, Grantham, FIT (1975). N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst, 54 401-14.
- Hongxing Z, Nancai Y, Wen S, et al (2008). Depletion of c-Myc inhibits human colon cancer colo 320 cells’ growth. Cancer Biother Radiopharm, 23, 229-37. https://doi.org/10.1089/cbr.2007.0441
- Huggins C, Lorreine CG, Filomena PB (1959). Critical significance of breast structure in the induction of mammary cancer in the rat. Proc Natl Acad Sci USA, 45, 1294-300. https://doi.org/10.1073/pnas.45.8.1294
- Imaoka T, Nishimura M, Teramoto A, et al (2005). Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int J Cancer, 115, 187-93. https://doi.org/10.1002/ijc.20904
- Inoue M, Shiramizu K (1999). Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. J Comp Pathol, 120, 169-75. https://doi.org/10.1053/jcpa.1998.0268
- Jain M, Arvanitis C, Chu K, et al (2002). Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science, 297, 102-4. https://doi.org/10.1126/science.1071489
- Jemal, A, Seigel R, Ward E, et al (2008) Cancer statistics 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
- Kessler JD, Kahle KT, Sun T, et al (2012). A Sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science, 335, 348-53. https://doi.org/10.1126/science.1212728
- Kininis M, Kraus WL (2008). A global view of transcriptional regulation by nuclear receptors: Gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal, 6, 5.
- Kubatka PE, Ahlersova I, Ahlers B, et al (2002). Variability of mammary carcinogenesis induction in female Sprague-Dawley and Wistar: Han Rats: The effect of season and age. Physiol Res, 51, 633-40.
- Liao DJ, Dickson RB (2000). c-Myc in breast cancer. Endocr Relat Cancer, 7, 143-64. https://doi.org/10.1677/erc.0.0070143
- Loscher W, Mevissen M, Haussler B (1997). Seasonal influence on 7,12-Dimethylbenz(a) anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions. Pharmacol Toxicol, 81, 265-70.
- Luo J, Solimini NL, Elledge SJ (2009). Principles of cancer therapy: oncogene and non-oncogene addiction. Cell, 136, 823-37. https://doi.org/10.1016/j.cell.2009.02.024
- Mariani-Costantini R, Escot C, Theillet C, et al (1988). In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res, 48, 199-205.
- Masramon L, Arribas R, Tartola S, et al (1998). Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer. Br J Cancer, 77, 2349-56. https://doi.org/10.1038/bjc.1998.390
- Mayilkumar K (2009). Evaluation of c-erbB2 and estrogen receptor expression in chemically induced rat mammary tumours. M.V.Sc. Thesis, Indian Veterinary Research Institute (IVRI), Izatnagar, Bareilly, U.P, India.
- McNeil CM, Sergio CM, Anderson LR, et al (2006). c-Myc overexpression and endocrine resistance in breast cancer. J Steroid Biochem Mol Biol, 102, 147-55. https://doi.org/10.1016/j.jsbmb.2006.09.028
-
Nakai T, Mochida J, Sakai D (2008). Synergistic role of c-Myc and ERK1/2 in the mitogenic response to TGF
$\beta$ -1 in cultured rat nucleus pulposes cells. Arthritis Res Ther, 10, 140. https://doi.org/10.1186/ar2567 - Nesbit CE, Tersak JM, Prochownik EV (1999). MYC oncogenes and human neoplastic disease. Oncogene, 18, 3004-16. https://doi.org/10.1038/sj.onc.1202746
- Oster SK, Ho CS, Soucie EL, et al (2002). The Myc oncogene: marvelously complex. Adv Cancer Res, 84, 81-154. https://doi.org/10.1016/S0065-230X(02)84004-0
- Pavelic ZP, Pavelic K, Carter CP, et al (1992). Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol, 118, 16-22. https://doi.org/10.1007/BF01192306
- Pawaiya RVS (2003). Pathology of chemically induced neoplasms and evaluation of molecular markers in diagnosis of animal tumours. Ph.D. Thesis, Indian Veterinary Research Institute (IVRI), Izatnagar, Bareilly, U.P, India.
- Pawaiya RVS (2012). Molecular Pathology of Chemically-Induced and Spontaneous Animal Tumors. LAP Lambert Academic Publishing GmbH & Co. KG, Saarbrucken, Germany.
- Pawaiya RVS, Ramkumar (2009). c-myc expression pattern in canine mammary and human breast cancer. Indian J Vet Pathol, 33, 49-52.
- Pietilainen T, Lipponen P, Aaltomaa S, et al (1995). Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res, 15, 959-64.
- Royds JA, Sharrard RM, Wanger B, et al (1992). Cellular localization of c-myc product in human colorectal epithelial neoplasia. J Pathol, 166, 225-33. https://doi.org/10.1002/path.1711660304
- Russo J, Russo IH (2000). Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia, 5, 187-200. https://doi.org/10.1023/A:1026443305758
- Sanchez-Pernaute A, Perez-Aguirre E, Cerdan FJ, et al (2005). Overexpression of c-myc and loss of heterozygosity on 2p, 3p, 5q, 17p and 18q in sporadic colorectal carcinoma. Rev Esp Enferm Dig, 97, 169-78.
- Shachaf CM, Kopelman AM, Arvanitis C, et al (2004). MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature, 431, 1112-7. https://doi.org/10.1038/nature03043
- Shen Q, Brown PH (2003). Novel agents for the prevention of breast cancer: Targeting transcription factors and signal transduction pathways. J Mammary Gland Biol Neoplasia, 8, 45-73. https://doi.org/10.1023/A:1025783221557
- Shibata M, Hariya T, Hatao M, et al (1999). Quantitative polymerase chain reaction using an external control mRNA for determination of gene expression in a heterogeneous cell population. Toxicol Sci, 49, 290-6. https://doi.org/10.1093/toxsci/49.2.290
- Siegel R, Ward E, Brawley O, et al (2011). Cancer statistics. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
- Sikora K, Evan G, Stewart J, et al (1985). Detection of the c-myc oncogene product in testicular cancer. Br J Cancer, 52, 171-6. https://doi.org/10.1038/bjc.1985.174
- Soucek L, Evan GI (2010). The ups and downs of Myc biology. Curr Opin Genet Dev, 20, 91-5. https://doi.org/10.1016/j.gde.2009.11.001
- Spicer DB, Sonenshein GE (1992). An antisense promoter of the murine c-myc gene is localized within intron 2. Mol Cell Biol, 12, 1324-9.
- Sumova A, Bendova Z, Sladek M, et al (2004). Seasonal molecular timekeeping within the rat circadian clock. Physiol Res, 53, 167-76.
- Tao L, Kramer PM, Wang W, et al (2002). Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. Carcinogenesis, 23, 1447-54. https://doi.org/10.1093/carcin/23.9.1447
- Thompson HJ, Adlakha H (1991). Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-l-nitrosourea. Cancer Res, 51, 3411-5.
- Thompson HJ, McGinley JN, Rothammer K, et al (1995). Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis, 16, 2407-11. https://doi.org/10.1093/carcin/16.10.2407
-
Vegh I, Salamanca RE (2007). Prolactin, TNF-
$\alpha$ and nitric oxide expression in nitroso-N-methylurea-induced-mammary tumours. J Carcinog, 6, 1-8. https://doi.org/10.1186/1477-3163-6-1 - Wang Y, Wu MC, Sham JS, et al (2002). Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer, 95, 2346-52. https://doi.org/10.1002/cncr.10963
- Wang YH, Liu S, Zhang G, et al (2005). Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res, 7, 220-8. https://doi.org/10.1186/bcr1306
- WHO World Cancer Report (2008). Introduction: Needs and prospects for cancer control. Chapter 1.1, p.15.
- Zhang X, Ge YL, Tian RH (2009). The knockdown of c-Myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo. Cell Mol Biol Lett, 14, 305-18. https://doi.org/10.2478/s11658-009-0001-9
Cited by
- Liposome-mediated Induction of Apoptosis of Human Hepatoma Cells by C-Myc Antisense Phosphorothioate Oligodeoxynucleotide and 5-Fluorouracil vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5529
- Identification of reference genes for qRT-PCR in human lung squamous-cell carcinoma by RNA-Seq vol.46, pp.4, 2014, https://doi.org/10.1093/abbs/gmt153
- N-Methyl-N-nitrosourea as a mammary carcinogenic agent vol.36, pp.12, 2015, https://doi.org/10.1007/s13277-015-3973-2